Abingdon Health Limited (ABDX) ORD GBP0.00025

- Add to watchlist
- Create an alert
- This stock can be held in a




Business summary
Abingdon Health PLC is primarily engaged in the development, manufacturing and distributing diagnostic devices and provides consultancy services to businesses in the diagnostics sector. The Company operates through three segments: Contract Development, Contract Manufacturing and Product Sales. The Contract Development segment comprises development work for third parties and is recognized over time based on a proportion of completion. The Contract Manufacturing segment comprises contract development and manufacturing activities. The Product Sales segment comprises the sale of ABC-19, pocket diagnostic products, progressive rod cone degeneration (PCRD) tests and antibodies for research use. Its products also include Seralite, which includes Free Light Chain (FLC) Serum. The Company’s geographical market include the United Kingdom, the United States/Canada, rest of world (ROW).
Contact details
Important dates
General stock information
- EPIC:
- ABDX
- ISIN:
- GB00BLF79J41
- Market cap:
- £13.02 million
- Shares in issue:
- 121.71 million
- Sector:
- No specific Industry
- Exchange:
- London Stock Exchange
- Currency:
- Sterling pence
- Indices:
- n/a
Key personnel

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.